Moss, 12 March 2026 Reference is made to Gentian Diagnostics ASA's (the "Company") stock exchange..
Moss, 12 March 2026 Gentian Diagnostics ASA (the "Company") has completed the offer of new shares to..
Moss, 19 February 2026 Gentian Diagnostics ASA ("Gentian") has today been notified that the following..
Moss, 13 February 2026 Gentian Diagnostics ASA ("Gentian") has today been notified that the following..
Moss, 12 February 2026 Gentian Diagnostics ASA ("Gentian") has today been notified that the following..
Moss, 12 February 2026 The Board of Directors of Gentian Diagnostics ASA proposes a dividend of NOK 0.60 per..
Gentian Diagnostics ASA announces an update on the development of its NT proBNP assay. Recent investigations..
Moss, 11 February 2026 Gentian Diagnostics ASA, a fast-growing developer and manufacturer of diagnostic..
Gentian Diagnostics ASA will present its fourth quarter 2025 results on 11 February 2026 at 09.00 CEST.